ID   PAR10_HUMAN             Reviewed;        1025 AA.
AC   Q53GL7; Q8N2I0; Q8WV05; Q96CH7; Q96K72;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   10-MAY-2017, entry version 117.
DE   RecName: Full=Poly [ADP-ribose] polymerase 10;
DE            Short=PARP-10;
DE            EC=2.4.2.30;
DE   AltName: Full=ADP-ribosyltransferase diphtheria toxin-like 10;
DE            Short=ARTD10;
GN   Name=PARP10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-630.
RC   TISSUE=Mammary gland, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 357-1025.
RC   TISSUE=Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION, FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   AND INTERACTION WITH MYC.
RX   PubMed=15674325; DOI=10.1038/sj.onc.1208410;
RA   Yu M., Schreek S., Cerni C., Schamberger C., Lesniewicz K., Poreba E.,
RA   Vervoorts J., Walsemann G., Groetzinger J., Kremmer E., Mehraein Y.,
RA   Mertsching J., Kraft R., Austen M., Luescher-Firzlaff J., Luescher B.;
RT   "PARP-10, a novel Myc-interacting protein with poly(ADP-ribose)
RT   polymerase activity, inhibits transformation.";
RL   Oncogene 24:1982-1993(2005).
RN   [5]
RP   FUNCTION, AND PHOSPHORYLATION AT THR-101.
RX   PubMed=16455663; DOI=10.1074/jbc.M506745200;
RA   Chou H.Y., Chou H.T., Lee S.C.;
RT   "CDK-dependent activation of poly(ADP-ribose) polymerase member 10
RT   (PARP10).";
RL   J. Biol. Chem. 281:15201-15207(2006).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-916, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [7]
RP   NOMENCLATURE.
RX   PubMed=20106667; DOI=10.1016/j.tibs.2009.12.003;
RA   Hottiger M.O., Hassa P.O., Luscher B., Schuler H., Koch-Nolte F.;
RT   "Toward a unified nomenclature for mammalian ADP-
RT   ribosyltransferases.";
RL   Trends Biochem. Sci. 35:208-219(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-663 AND SER-1011, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378; SER-423; SER-431
RP   AND SER-663, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   INTERACTION WITH PARP14, AND MUTAGENESIS OF GLY-888.
RX   PubMed=23473667; DOI=10.1016/j.str.2012.12.019;
RA   Forst A.H., Karlberg T., Herzog N., Thorsell A.G., Gross A.,
RA   Feijs K.L., Verheugd P., Kursula P., Nijmeijer B., Kremmer E.,
RA   Kleine H., Ladurner A.G., Schuler H., Luscher B.;
RT   "Recognition of mono-ADP-ribosylated ARTD10 substrates by ARTD8
RT   macrodomains.";
RL   Structure 21:462-475(2013).
RN   [11]
RP   STRUCTURE BY NMR OF 7-101.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the RRM domain in the human poly (ADP-ribose)
RT   polymerase family, member 10 variant.";
RL   Submitted (FEB-2007) to the PDB data bank.
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 809-1017.
RG   Structural genomics consortium (SGC);
RT   "Human poly(ADP-ribose) polymerase 10, catalytic fragment in complex
RT   with an inhibitor 3-aminobenzamide.";
RL   Submitted (JUN-2009) to the PDB data bank.
CC   -!- FUNCTION: May play a role in cell proliferation. May be required
CC       for the maintenance of cell cycle progression.
CC       {ECO:0000269|PubMed:15674325, ECO:0000269|PubMed:16455663}.
CC   -!- CATALYTIC ACTIVITY: NAD(+) + (ADP-D-ribosyl)(n)-acceptor =
CC       nicotinamide + (ADP-D-ribosyl)(n+1)-acceptor.
CC       {ECO:0000255|PROSITE-ProRule:PRU00397}.
CC   -!- SUBUNIT: Interacts with MYC (PubMed:15674325). Interacts with
CC       PARP14 (PubMed:23473667). {ECO:0000269|PubMed:15674325,
CC       ECO:0000269|PubMed:23473667}.
CC   -!- INTERACTION:
CC       Q9Y530:OARD1; NbExp=3; IntAct=EBI-2857573, EBI-8502288;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus
CC       {ECO:0000269|PubMed:15674325}. Cytoplasm
CC       {ECO:0000269|PubMed:15674325}. Note=Shuttles between the nuclear
CC       and cytoplasmic compartment. A subpopulation concentrates in the
CC       nucleolus during late G1/S phase.
CC   -!- TISSUE SPECIFICITY: Highly expressed in spleen and thymus.
CC       Intermediate levels in liver, kidney, pancreas, prostate, testis,
CC       ovary, intestine, and leukocytes. Low expression in heart, brain,
CC       placenta, lung, skeletal muscle, and colon.
CC       {ECO:0000269|PubMed:15674325}.
CC   -!- PTM: Stimulated through its phosphorylation by CDK2. Acquires CDK-
CC       dependent phosphorylation through late-G1 to S phase, and from
CC       prometaphase to cytokinesis in the nucleolar organizing regions.
CC       Phosphorylation is suppressed in growth-arrested cells.
CC       {ECO:0000269|PubMed:16455663}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11498.1; Type=Frameshift; Positions=965; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK027370; BAB55067.1; -; mRNA.
DR   EMBL; AK075250; BAC11498.1; ALT_SEQ; mRNA.
DR   EMBL; AK222914; BAD96634.1; -; mRNA.
DR   EMBL; BC014229; AAH14229.2; -; mRNA.
DR   EMBL; BC019030; AAH19030.2; -; mRNA.
DR   CCDS; CCDS34960.1; -.
DR   RefSeq; NP_116178.2; NM_032789.4.
DR   UniGene; Hs.348609; -.
DR   PDB; 2DHX; NMR; -; A=10-100.
DR   PDB; 3HKV; X-ray; 2.10 A; A/B=809-1017.
DR   PDB; 5LX6; X-ray; 1.25 A; A/B=819-1007.
DR   PDBsum; 2DHX; -.
DR   PDBsum; 3HKV; -.
DR   PDBsum; 5LX6; -.
DR   ProteinModelPortal; Q53GL7; -.
DR   SMR; Q53GL7; -.
DR   BioGrid; 124320; 17.
DR   IntAct; Q53GL7; 4.
DR   MINT; MINT-8408778; -.
DR   STRING; 9606.ENSP00000325618; -.
DR   BindingDB; Q53GL7; -.
DR   ChEMBL; CHEMBL2429708; -.
DR   iPTMnet; Q53GL7; -.
DR   PhosphoSitePlus; Q53GL7; -.
DR   BioMuta; PARP10; -.
DR   DMDM; 116248563; -.
DR   EPD; Q53GL7; -.
DR   MaxQB; Q53GL7; -.
DR   PaxDb; Q53GL7; -.
DR   PeptideAtlas; Q53GL7; -.
DR   PRIDE; Q53GL7; -.
DR   Ensembl; ENST00000313028; ENSP00000325618; ENSG00000178685.
DR   GeneID; 84875; -.
DR   KEGG; hsa:84875; -.
DR   UCSC; uc003zal.5; human.
DR   CTD; 84875; -.
DR   GeneCards; PARP10; -.
DR   H-InvDB; HIX0201285; -.
DR   HGNC; HGNC:25895; PARP10.
DR   HPA; HPA028122; -.
DR   HPA; HPA052427; -.
DR   MIM; 609564; gene.
DR   neXtProt; NX_Q53GL7; -.
DR   OpenTargets; ENSG00000178685; -.
DR   PharmGKB; PA134892853; -.
DR   eggNOG; ENOG410IH3S; Eukaryota.
DR   eggNOG; ENOG411034Y; LUCA.
DR   GeneTree; ENSGT00760000119084; -.
DR   HOVERGEN; HBG068843; -.
DR   InParanoid; Q53GL7; -.
DR   KO; K15261; -.
DR   PhylomeDB; Q53GL7; -.
DR   TreeFam; TF328965; -.
DR   Reactome; R-HSA-197264; Nicotinamide salvaging.
DR   ChiTaRS; PARP10; human.
DR   EvolutionaryTrace; Q53GL7; -.
DR   GeneWiki; PARP10; -.
DR   GenomeRNAi; 84875; -.
DR   PRO; PR:Q53GL7; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000178685; -.
DR   CleanEx; HS_PARP10; -.
DR   ExpressionAtlas; Q53GL7; baseline and differential.
DR   Genevisible; Q53GL7; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0070530; F:K63-linked polyubiquitin binding; IMP:UniProtKB.
DR   GO; GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IMP:UniProtKB.
DR   GO; GO:0034356; P:NAD biosynthesis via nicotinamide riboside salvage pathway; TAS:Reactome.
DR   GO; GO:0048147; P:negative regulation of fibroblast proliferation; IDA:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0033159; P:negative regulation of protein import into nucleus, translocation; IMP:UniProtKB.
DR   GO; GO:1900045; P:negative regulation of protein K63-linked ubiquitination; IMP:UniProtKB.
DR   GO; GO:0045071; P:negative regulation of viral genome replication; IMP:UniProtKB.
DR   GO; GO:0006471; P:protein ADP-ribosylation; IMP:UniProtKB.
DR   GO; GO:0070213; P:protein auto-ADP-ribosylation; IMP:UniProtKB.
DR   GO; GO:0070212; P:protein poly-ADP-ribosylation; IDA:UniProtKB.
DR   GO; GO:0010847; P:regulation of chromatin assembly; IDA:UniProtKB.
DR   CDD; cd12547; RRM1_2_PAR10; 2.
DR   InterPro; IPR034464; PAR10_RRM1_2.
DR   InterPro; IPR012317; Poly(ADP-ribose)pol_cat_dom.
DR   Pfam; PF00644; PARP; 1.
DR   PROSITE; PS51059; PARP_CATALYTIC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Glycosyltransferase; NAD; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase.
FT   CHAIN         1   1025       Poly [ADP-ribose] polymerase 10.
FT                                /FTId=PRO_0000252435.
FT   DOMAIN      806   1025       PARP catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00397}.
FT   REGION      700    907       Myc binding.
FT   MOTIF       650    667       Ubiquitin-interacting.
FT   MOTIF       673    690       Ubiquitin-interacting.
FT   COMPBIAS    186    193       Poly-Leu.
FT   COMPBIAS    588    697       Glu-rich.
FT   MOD_RES     101    101       Phosphothreonine.
FT                                {ECO:0000269|PubMed:16455663}.
FT   MOD_RES     378    378       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     423    423       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     431    431       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     663    663       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     916    916       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1011   1011       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     249    249       I -> V (in dbSNP:rs11136344).
FT                                /FTId=VAR_027859.
FT   VARIANT     395    395       L -> P (in dbSNP:rs11136343).
FT                                /FTId=VAR_027860.
FT   VARIANT     630    630       V -> A (in dbSNP:rs11544989).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_027861.
FT   MUTAGEN     888    888       G->W: Abolishes catalytic activity;
FT                                abolishes interaction with PARP14.
FT                                {ECO:0000305|PubMed:23473667}.
FT   CONFLICT    313    313       M -> I (in Ref. 1; BAB55067).
FT                                {ECO:0000305}.
FT   CONFLICT    518    518       P -> S (in Ref. 1; BAB55067).
FT                                {ECO:0000305}.
FT   CONFLICT    813    813       L -> P (in Ref. 3; AAH14229).
FT                                {ECO:0000305}.
FT   CONFLICT    922    922       R -> K (in Ref. 1; BAB55067).
FT                                {ECO:0000305}.
FT   CONFLICT   1013   1013       D -> G (in Ref. 2; BAD96634).
FT                                {ECO:0000305}.
FT   STRAND       12     17       {ECO:0000244|PDB:2DHX}.
FT   HELIX        24     32       {ECO:0000244|PDB:2DHX}.
FT   TURN         34     37       {ECO:0000244|PDB:2DHX}.
FT   STRAND       43     48       {ECO:0000244|PDB:2DHX}.
FT   STRAND       51     55       {ECO:0000244|PDB:2DHX}.
FT   HELIX        59     66       {ECO:0000244|PDB:2DHX}.
FT   STRAND       72     77       {ECO:0000244|PDB:2DHX}.
FT   STRAND       79     82       {ECO:0000244|PDB:2DHX}.
FT   STRAND      819    822       {ECO:0000244|PDB:5LX6}.
FT   STRAND      825    827       {ECO:0000244|PDB:3HKV}.
FT   HELIX       828    839       {ECO:0000244|PDB:5LX6}.
FT   HELIX       842    844       {ECO:0000244|PDB:5LX6}.
FT   TURN        845    847       {ECO:0000244|PDB:5LX6}.
FT   STRAND      848    856       {ECO:0000244|PDB:5LX6}.
FT   HELIX       859    875       {ECO:0000244|PDB:5LX6}.
FT   STRAND      883    889       {ECO:0000244|PDB:5LX6}.
FT   HELIX       891    893       {ECO:0000244|PDB:5LX6}.
FT   HELIX       894    900       {ECO:0000244|PDB:5LX6}.
FT   HELIX       904    906       {ECO:0000244|PDB:5LX6}.
FT   STRAND      916    923       {ECO:0000244|PDB:5LX6}.
FT   HELIX       924    927       {ECO:0000244|PDB:5LX6}.
FT   TURN        930    932       {ECO:0000244|PDB:5LX6}.
FT   STRAND      941    948       {ECO:0000244|PDB:5LX6}.
FT   STRAND      952    955       {ECO:0000244|PDB:5LX6}.
FT   STRAND      961    963       {ECO:0000244|PDB:3HKV}.
FT   STRAND      971    974       {ECO:0000244|PDB:5LX6}.
FT   STRAND      976    980       {ECO:0000244|PDB:5LX6}.
FT   STRAND      982    984       {ECO:0000244|PDB:5LX6}.
FT   STRAND      987    990       {ECO:0000244|PDB:5LX6}.
FT   STRAND      995   1006       {ECO:0000244|PDB:5LX6}.
SQ   SEQUENCE   1025 AA;  109998 MW;  AC9CCFCF9B83A989 CRC64;
     MVAMAEAEAG VAVEVRGLPP AVPDELLTLY FENRRRSGGG PVLSWQRLGC GGVLTFREPA
     DAERVLAQAD HELHGAQLSL RPAPPRAPAR LLLQGLPPGT TPQRLEQHVQ ALLRASGLPV
     QPCCALASPR PDRALVQLPK PLSEADVRVL EEQAQNLGLE GTLVSLARVP QARAVRVVGD
     GASVDLLLLE LYLENERRSG GGPLEDLQRL PGPLGTVASF QQWQVAERVL QQEHRLQGSE
     LSLVPHYDIL EPEELAENTS GGDHPSTQGP RATKHALLRT GGLVTALQGA GTVTMGSGEE
     PGQSGASLRT GPMVQGRGIM TTGSGQEPGQ SGTSLRTGPM GSLGQAEQVS SMPMGSLEHE
     GLVSLRPVGL QEQEGPMSLG PVGSAGPVET SKGLLGQEGL VEIAMDSPEQ EGLVGPMEIT
     MGSLEKAGPV SPGCVKLAGQ EGLVEMVLLM EPGAMRFLQL YHEDLLAGLG DVALLPLEGP
     DMTGFRLCGA QASCQAAEEF LRSLLGSISC HVLCLEHPGS ARFLLGPEGQ HLLQGLEAQF
     QCVFGTERLA TATLDTGLEE VDPTEALPVL PGNAHTLWTP DSTGGDQEDV SLEEVRELLA
     TLEGLDLDGE DWLPRELEEE GPQEQPEEEV TPGHEEEEPV APSTVAPRWL EEEAALQLAL
     HRSLEPQGQV AEQEEAAALR QALTLSLLEQ PPLEAEEPPD GGTDGKAQLV VHSAFEQDVE
     ELDRALRAAL EVHVQEETVG PWRRTLPAEL RARLERCHGV SVALRGDCTI LRGFGAHPAR
     AARHLVALLA GPWDQSLAFP LAASGPTLAG QTLKGPWNNL ERLAENTGEF QEVVRAFYDT
     LDAARSSIRV VRVERVSHPL LQQQYELYRE RLLQRCERRP VEQVLYHGTT APAVPDICAH
     GFNRSFCGRN ATVYGKGVYF ARRASLSVQD RYSPPNADGH KAVFVARVLT GDYGQGRRGL
     RAPPLRGPGH VLLRYDSAVD CICQPSIFVI FHDTQALPTH LITCEHVPRA SPDDPSGLPG
     RSPDT
//
